Information on Katalysen Ventures' Financial Exposure within the Payer Group of Companies

The following is a communique from Katalysen Ventures AB (publ) (the "Company", "Katalysen Ventures") regarding the Company's total financial exposure within the Payer corporate group of companies (the "Payer Group"). Note that the following is merely a disclosure of information, and that no new adjustment has been made to the estimated value of the Payer Group in the Company's books or portfolio. The estimated value of Katalysen Ventures' portfolio of shares, options, and convertibles remains 171.5 MSEK , as last communicated on 2023-12-06.

Following the announcement made on 2023-12-06, Katalysen Ventures' total financial exposure to the Payer Group amounts to 9.7 MSEK (excluding accrued interest).

Within this total exposure, 3.0 MSEK is attributed to the combined value of common shares and preference shares, while 6.7 MSEK is linked to loans and preference shares with first (highest) priority.

Peter Almberg, CEO of Katalysen Ventures, comments: “To the best of our knowledge, the status quo within the Payer corporate group persists. Nonetheless, given the ongoing uncertainty, we are committed to enhancing the transparency of our exposure to our shareholders and the broader market with this declaration."